sirtex acquisition?sirtex biotech conference I found this quite interesting on theYahoo business site under Pfizer.
Top > Business & Finance > Investments > Sectors > Healthcare > Major Drugs > PFE (Pfizer Inc.
May 12; :IBD reports that small Australian biotech company that utilizes Sir Spheres technology that is finding increasing effectiveness in destroying metastatic liver tumors will be showcased at an upcoming Bear Stearns Biotechnology conference. The Sirtex Medical co is publicly traded on the ASX with a market cap of 130 Million in Australian currency. The Sir Spheres have been found to be very effective when used in combination with Pfizer's newest chemotherapy drugs to fight colorectal cancer that has metastasized to the liver and is currently conducting trials with Sirtex. The co. is tightly held. The Sir Spheres technology has market potential in the one billion USD range in the high margined oncology business. Recent large trial results for the colorectal to liver metastasis indication were released at a recent scientific conference in Scottsdale Arizona and are to be published in the American Journal of Clinical Oncology in the May issue.
All Subject Message Text Authors
ADVERTISEMENT
PFE Snapshot
PFE 24.81 -0.23 -0.92%
Delayed data
providers - disclaimer
Symbol Lookup
-----------------------------------------------------------------------------
--------------------------------------------------------------------------------
Copyright © 2006 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Copyright/IP Policy - Guidelines - Help - Ad Feedback
Add to My Watchlist
What is My Watchlist?